The core activity of Neurosoft Bioelectronics is the development and manufacturing of brain-computer interfaces (BCIs), particularly soft, elastic brain interfaces that offer improved bio-integration and minimal mechanical mismatch with neural tissues. These interfaces are used in combination with artificial intelligence (AI) to enable the analysis of brain data, the detection of biomarkers, the optimization of neuromodulation, and the decoding of motor and linguistic intentions. The goal is to improve the treatment and rehabilitation of patients with neurological disorders.